2017, Serie Desarrollo y cooperación, ISBN 8490973369, 220
Book
2.
Full Text
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register
Internal and Emergency Medicine, ISSN 1828-0447, 12/2018, Volume 13, Issue 8, pp. 1191 - 1200
As a consequence of population aging, we have witnessed in internal medicine hospital wards a progressive shift from a population of in-patients relatively...
Polypharmacy | Medicine & Public Health | Medication reconciliation | Inappropriate prescription | Internal Medicine | Deprescribing | Multimorbidity | Chronic diseases | Neurosciences | Aged | Medicine | Aging | Internal medicine | Elderly | Patients
Polypharmacy | Medicine & Public Health | Medication reconciliation | Inappropriate prescription | Internal Medicine | Deprescribing | Multimorbidity | Chronic diseases | Neurosciences | Aged | Medicine | Aging | Internal medicine | Elderly | Patients
Journal Article
Haematologica, ISSN 0390-6078, 04/2010, Volume 95, Issue 4, pp. 644 - 650
Background The aim of this study was to evaluate prognostic factors, treatments and outcome of invasive aspergillosis in patients with acute myeloid leukemia...
Acute myeloid leukaemia | Antifungal treatment | Aspergillosis | MORTALITY | CASPOFUNGIN | POLYMORPHONUCLEAR LEUKOCYTES | antifungal treatment | ANTIFUNGAL ACTIVITY | AMPHOTERICIN-B | FUNGAL-INFECTIONS | THERAPY | IMMUNOCOMPROMISED PATIENTS | acute myeloid leukaemia | FORMULATIONS | aspergillosis | HEMATOLOGICAL MALIGNANCIES | HEMATOLOGY | Prospective Studies | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - complications | Antifungal Agents - therapeutic use | Leukemia, Myeloid, Acute - microbiology | Young Adult | Aspergillosis - etiology | Voriconazole | Aspergillosis - mortality | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Registries | Aspergillosis - drug therapy | Triazoles - therapeutic use | Survival Rate | Treatment Outcome | Pyrimidines - therapeutic use | Adolescent | Echinocandins - therapeutic use | Aged | Aspergillus - physiology | Amphotericin B - therapeutic use | Lipopeptides | Original
Acute myeloid leukaemia | Antifungal treatment | Aspergillosis | MORTALITY | CASPOFUNGIN | POLYMORPHONUCLEAR LEUKOCYTES | antifungal treatment | ANTIFUNGAL ACTIVITY | AMPHOTERICIN-B | FUNGAL-INFECTIONS | THERAPY | IMMUNOCOMPROMISED PATIENTS | acute myeloid leukaemia | FORMULATIONS | aspergillosis | HEMATOLOGICAL MALIGNANCIES | HEMATOLOGY | Prospective Studies | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - complications | Antifungal Agents - therapeutic use | Leukemia, Myeloid, Acute - microbiology | Young Adult | Aspergillosis - etiology | Voriconazole | Aspergillosis - mortality | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Registries | Aspergillosis - drug therapy | Triazoles - therapeutic use | Survival Rate | Treatment Outcome | Pyrimidines - therapeutic use | Adolescent | Echinocandins - therapeutic use | Aged | Aspergillus - physiology | Amphotericin B - therapeutic use | Lipopeptides | Original
Journal Article
Journal of Cardiovascular Electrophysiology, ISSN 1045-3873, 06/2019, Volume 30, Issue 6, pp. 902 - 909
Introduction Efficacy of cryoballoon ablation depends on balloon‐tissue contact and ablation duration. Prolonged duration may increase extracardiac...
dormant conduction | atrial fibrillation | cryoballoon ablation | pulmonary vein isolation | time‐to‐isolation | time-to-isolation | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | SAFETY | PREDICTORS | FISTULA | RADIOFREQUENCY ABLATION | ATRIAL-FIBRILLATION | Medicine, Experimental | Medical research | Ablation (Surgery) | Atrial fibrillation | Conduction | Randomization | Temperature | Fibrillation | Phrenic nerve | Complications | Ablation | Optimization | Esophagus | Original
dormant conduction | atrial fibrillation | cryoballoon ablation | pulmonary vein isolation | time‐to‐isolation | time-to-isolation | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | SAFETY | PREDICTORS | FISTULA | RADIOFREQUENCY ABLATION | ATRIAL-FIBRILLATION | Medicine, Experimental | Medical research | Ablation (Surgery) | Atrial fibrillation | Conduction | Randomization | Temperature | Fibrillation | Phrenic nerve | Complications | Ablation | Optimization | Esophagus | Original
Journal Article
5.
Full Text
International Congress of Drug Therapy in HIV Infection 23‐26 October 2016, Glasgow, UK
Journal of the International AIDS Society, ISSN 1758-2652, 10/2016, Volume 19, Issue 8(Suppl 7), pp. 21487 - n/a
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 18, pp. 1954 - 1959
Abstract Background A recent meta-analysis demonstrated a survival benefit in post-infarction patients whose ventricular tachycardia (VT) was rendered...
Cardiovascular | Internal Medicine | mortality | ablation | CARDIAC & CARDIOVASCULAR SYSTEMS | RECURRENCE | NONINDUCIBILITY | END-POINT | Recurrence | Myocardial Infarction - mortality | Electric Stimulation | Age Factors | Follow-Up Studies | Humans | Tachycardia, Ventricular - etiology | Catheter Ablation | Male | Myocardial Infarction - complications | Tachycardia, Ventricular - mortality | Tachycardia, Ventricular - surgery | Atrial Fibrillation - epidemiology | Diabetes Mellitus - epidemiology | Female | Aged | Cohort Studies | Sects | Ventricular tachycardia | Ablation (Surgery) | Cardiac arrhythmia | Heart attacks | Mortality | Catheters
Cardiovascular | Internal Medicine | mortality | ablation | CARDIAC & CARDIOVASCULAR SYSTEMS | RECURRENCE | NONINDUCIBILITY | END-POINT | Recurrence | Myocardial Infarction - mortality | Electric Stimulation | Age Factors | Follow-Up Studies | Humans | Tachycardia, Ventricular - etiology | Catheter Ablation | Male | Myocardial Infarction - complications | Tachycardia, Ventricular - mortality | Tachycardia, Ventricular - surgery | Atrial Fibrillation - epidemiology | Diabetes Mellitus - epidemiology | Female | Aged | Cohort Studies | Sects | Ventricular tachycardia | Ablation (Surgery) | Cardiac arrhythmia | Heart attacks | Mortality | Catheters
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 12/2017, Volume 88, Issue 12, pp. 1094 - 1097
Introduction No adequate immunotherapy has so far been shown to be effective in anti-myelin-associated glycoprotein (MAG) antibody neuropathy. 1 Rituximab was...
antibody | myelin-associated glycoprotein (MAG) | Waldenstrom's Macroglobulinemia | neuropathy | rituximab | IgM paraprotein | monoclonal gammopathy of undetermined significance (MGUS) | SURGERY | PSYCHIATRY | CLINICAL NEUROLOGY | Ethics | Medical research | Immunoglobulins | Statistical analysis | Hematology | Laboratories | Immunotherapy | Age
antibody | myelin-associated glycoprotein (MAG) | Waldenstrom's Macroglobulinemia | neuropathy | rituximab | IgM paraprotein | monoclonal gammopathy of undetermined significance (MGUS) | SURGERY | PSYCHIATRY | CLINICAL NEUROLOGY | Ethics | Medical research | Immunoglobulins | Statistical analysis | Hematology | Laboratories | Immunotherapy | Age
Journal Article
Journal of Neurology, ISSN 0340-5354, 12/2018, Volume 265, Issue 12, pp. 2927 - 2933
Although anti-myelin-associated glycoprotein (MAG) antibody neuropathy is reported as a slowly progressive disease, it can lead to significant disability and...
Neurology | Neurosciences | Pain | Medicine & Public Health | Rehabilitation | MGUS | Balance | Neuroradiology | Chronic inflammatory polyneuropathy | Walking ability | DEMYELINATING POLYNEUROPATHY | VALIDATION | CLINICAL NEUROLOGY | AUTONOMY | IMPACT | OUTCOME MEASURES | RITUXIMAB | MONOCLONAL GAMMOPATHY | HANDICAP | PARTICIPATION | Autoantibodies - metabolism | Cross-Sectional Studies | Humans | Fatigue | Male | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - physiopathology | Walking | Myelin-Associated Glycoprotein - immunology | Social Behavior | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - rehabilitation | Quality of Life | Female | Aged | Postural Balance | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - psychology | Causes of | Care and treatment | Research | Peripheral nerve diseases | Patient outcomes | Quality of life | Myelin | Clinical trials | Neuropathy | Autonomy | Regression analysis | Myelin-associated glycoprotein | Original Communication
Neurology | Neurosciences | Pain | Medicine & Public Health | Rehabilitation | MGUS | Balance | Neuroradiology | Chronic inflammatory polyneuropathy | Walking ability | DEMYELINATING POLYNEUROPATHY | VALIDATION | CLINICAL NEUROLOGY | AUTONOMY | IMPACT | OUTCOME MEASURES | RITUXIMAB | MONOCLONAL GAMMOPATHY | HANDICAP | PARTICIPATION | Autoantibodies - metabolism | Cross-Sectional Studies | Humans | Fatigue | Male | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - physiopathology | Walking | Myelin-Associated Glycoprotein - immunology | Social Behavior | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - rehabilitation | Quality of Life | Female | Aged | Postural Balance | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - psychology | Causes of | Care and treatment | Research | Peripheral nerve diseases | Patient outcomes | Quality of life | Myelin | Clinical trials | Neuropathy | Autonomy | Regression analysis | Myelin-associated glycoprotein | Original Communication
Journal Article
Journal of the Peripheral Nervous System, ISSN 1085-9489, 09/2019, Volume 24, Issue 3, pp. 276 - 282
In this study, we assessed the modifications over time of daily activities and quality of life (QoL) in 32 subjects with anti‐myelin‐glycoprotein (MAG)...
quality of life (QoL) | anti‐MAG antibodies | peripheral neuropathy | International Classification of Functioning, Disability and Health (ICF) | follow‐up | Disability and Health (ICF) | PROGNOSIS | VALIDATION | IMMUNE-MEDIATED NEUROPATHIES | International Classification of Functioning | NEUROSCIENCES | CLINICAL NEUROLOGY | AUTONOMY | anti-MAG antibodies | follow-up | IMPACT | OUTCOME MEASURES | PAIN | DISABILITY | MAG NEUROPATHY | PARTICIPATION | Viral antibodies | Antibodies | Limbs | Pain | Myelin | Rituximab | Glycoproteins | Neuropathy | Polyneuropathy | Myelin-associated glycoprotein | Quality of life
quality of life (QoL) | anti‐MAG antibodies | peripheral neuropathy | International Classification of Functioning, Disability and Health (ICF) | follow‐up | Disability and Health (ICF) | PROGNOSIS | VALIDATION | IMMUNE-MEDIATED NEUROPATHIES | International Classification of Functioning | NEUROSCIENCES | CLINICAL NEUROLOGY | AUTONOMY | anti-MAG antibodies | follow-up | IMPACT | OUTCOME MEASURES | PAIN | DISABILITY | MAG NEUROPATHY | PARTICIPATION | Viral antibodies | Antibodies | Limbs | Pain | Myelin | Rituximab | Glycoproteins | Neuropathy | Polyneuropathy | Myelin-associated glycoprotein | Quality of life
Journal Article
Journal of Contemporary Psychotherapy, ISSN 0022-0116, 12/2013, Volume 43, Issue 4, pp. 207 - 221
Since the late 1990s the use of virtual reality (VR) has expanded in the field of mental disorders. During this time, several VR-based applications have been...
Personality and Social Psychology | Obesity | Public Health | Treatment | Medicine & Public Health | Binge eating disorders | Virtual reality | Eating disorders | Clinical Psychology | Review | Psychiatry | Cognitive therapy | Body image | Emergency medicine | Food habits | Compulsive eating | Obesitat | Realitat virtual | Trastorns de la conducta alimentària
Personality and Social Psychology | Obesity | Public Health | Treatment | Medicine & Public Health | Binge eating disorders | Virtual reality | Eating disorders | Clinical Psychology | Review | Psychiatry | Cognitive therapy | Body image | Emergency medicine | Food habits | Compulsive eating | Obesitat | Realitat virtual | Trastorns de la conducta alimentària
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5943 - 5943
Abstract A proper assessment of elderly patients is a relevant clinical problem in the onco-hematological setting. In this context, age and extra-hematological...
Journal Article
Pacing and Clinical Electrophysiology, ISSN 0147-8389, 02/2019, Volume 42, Issue 2, pp. 208 - 215
Background The posterior wall of the left atrium (LA) is a well‐known substrate for atrial fibrillation (AF) maintenance. Isolation of the posterior wall...
catheter ablation | left atrial box lesion | persistent atrial fibrillation ablation | substrate modification | CARDIAC & CARDIOVASCULAR SYSTEMS | ENGINEERING, BIOMEDICAL | SURGICAL ABLATION | FOLLOW-UP | TIME | BIPOLAR | PULMONARY VEIN ISOLATION | PATIENT | POSTERIOR WALL ISOLATION | Ablation (Surgery) | Tachycardia | Atrial fibrillation | Cardiac patients | Electrocardiogram | Anti-arrhythmia drugs | Electrocardiography | EKG | Cardiac arrhythmia | Atrium | Mitral valve | Arrhythmia | Multivariate analysis | Fibrillation | Maps | Computed tomography | Surgery | Surface area | Electrophysiology
catheter ablation | left atrial box lesion | persistent atrial fibrillation ablation | substrate modification | CARDIAC & CARDIOVASCULAR SYSTEMS | ENGINEERING, BIOMEDICAL | SURGICAL ABLATION | FOLLOW-UP | TIME | BIPOLAR | PULMONARY VEIN ISOLATION | PATIENT | POSTERIOR WALL ISOLATION | Ablation (Surgery) | Tachycardia | Atrial fibrillation | Cardiac patients | Electrocardiogram | Anti-arrhythmia drugs | Electrocardiography | EKG | Cardiac arrhythmia | Atrium | Mitral valve | Arrhythmia | Multivariate analysis | Fibrillation | Maps | Computed tomography | Surgery | Surface area | Electrophysiology
Journal Article
European Eating Disorders Review, ISSN 1072-4133, 11/2017, Volume 25, Issue 6, pp. 479 - 490
A question that arises from the literature on therapy is whether second‐level treatment is effective for patients with recurrent binge eating who fail...
bulimia nervosa | treatment | virtual reality | binge eating disorders | cue exposure | MEDICAL COMPLICATIONS | FUTURE-DIRECTIONS | DSM-5 | FOLLOW-UP | PSYCHOLOGY, CLINICAL | RESPONSE PREVENTION | PSYCHOLOGICAL TREATMENTS | COGNITIVE-BEHAVIORAL THERAPY | BODY | SEVERITY | FOOD | Cues | Binge-Eating Disorder - therapy | Cognitive Therapy - methods | Bulimia Nervosa - therapy | Craving | Humans | Anxiety - psychology | Male | Treatment Outcome | Bulimia Nervosa - psychology | Binge-Eating Disorder - psychology | Virtual Reality Exposure Therapy | Adult | Female | Medicine, Experimental | Medical research | Behavioral health care | Cognitive therapy | Comparative analysis | Compulsive eating
bulimia nervosa | treatment | virtual reality | binge eating disorders | cue exposure | MEDICAL COMPLICATIONS | FUTURE-DIRECTIONS | DSM-5 | FOLLOW-UP | PSYCHOLOGY, CLINICAL | RESPONSE PREVENTION | PSYCHOLOGICAL TREATMENTS | COGNITIVE-BEHAVIORAL THERAPY | BODY | SEVERITY | FOOD | Cues | Binge-Eating Disorder - therapy | Cognitive Therapy - methods | Bulimia Nervosa - therapy | Craving | Humans | Anxiety - psychology | Male | Treatment Outcome | Bulimia Nervosa - psychology | Binge-Eating Disorder - psychology | Virtual Reality Exposure Therapy | Adult | Female | Medicine, Experimental | Medical research | Behavioral health care | Cognitive therapy | Comparative analysis | Compulsive eating
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 5, pp. 503 - 509
The type I interferon system is integral to human antiviral immunity. However, inappropriate stimulation or defective negative regulation of this system can...
AICARDI-GOUTIERES-SYNDROME | DYSCHROMATOSIS SYMMETRICA HEREDITARIA | LUPUS | AUTOIMMUNITY | TREX1 | GENETICS & HEREDITY | DISORDERS | MICE | MDA5 FILAMENTS | DSRNA RECOGNITION | EXPRESSION SIGNATURE | Nervous System Malformations - immunology | Humans | Models, Molecular | Molecular Sequence Data | Signal Transduction - genetics | Interferon Type I - immunology | Mutation - genetics | Sequence Analysis, DNA | Interferon-Induced Helicase, IFIH1 | Microsatellite Repeats - genetics | Autoimmune Diseases of the Nervous System - immunology | DEAD-box RNA Helicases - genetics | Exome - genetics | Phenotype | Analysis of Variance | Base Sequence | Autoimmune Diseases of the Nervous System - genetics | HEK293 Cells | Electrophoretic Mobility Shift Assay | Nervous System Malformations - genetics | Spectrum Analysis | DEAD-box RNA Helicases - chemistry | Real-Time Polymerase Chain Reaction | Cell receptors | Gene mutations | Interferon | Genetic aspects | Genetic regulation | Health aspects | Proteins | Studies | Genotype & phenotype | Hospitals | Biomedical research | Disease | Womens health | Pathogenesis | Families & family life | Genomes | Mutation
AICARDI-GOUTIERES-SYNDROME | DYSCHROMATOSIS SYMMETRICA HEREDITARIA | LUPUS | AUTOIMMUNITY | TREX1 | GENETICS & HEREDITY | DISORDERS | MICE | MDA5 FILAMENTS | DSRNA RECOGNITION | EXPRESSION SIGNATURE | Nervous System Malformations - immunology | Humans | Models, Molecular | Molecular Sequence Data | Signal Transduction - genetics | Interferon Type I - immunology | Mutation - genetics | Sequence Analysis, DNA | Interferon-Induced Helicase, IFIH1 | Microsatellite Repeats - genetics | Autoimmune Diseases of the Nervous System - immunology | DEAD-box RNA Helicases - genetics | Exome - genetics | Phenotype | Analysis of Variance | Base Sequence | Autoimmune Diseases of the Nervous System - genetics | HEK293 Cells | Electrophoretic Mobility Shift Assay | Nervous System Malformations - genetics | Spectrum Analysis | DEAD-box RNA Helicases - chemistry | Real-Time Polymerase Chain Reaction | Cell receptors | Gene mutations | Interferon | Genetic aspects | Genetic regulation | Health aspects | Proteins | Studies | Genotype & phenotype | Hospitals | Biomedical research | Disease | Womens health | Pathogenesis | Families & family life | Genomes | Mutation
Journal Article